Literature DB >> 15734052

Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen.

María J Dus Santos1, Consuelo Carrillo, Fernando Ardila, Raúl D Ríos, Pascual Franzone, María E Piccone, Andrés Wigdorovitz, Manuel V Borca.   

Abstract

The use of transgenic plants as vectors for the expression of viral and bacterial antigens has been increasingly tested as an alternative methodology for the production of experimental vaccines. Here, we report the production of transgenic alfalfa plants containing the genes encoding the polyprotein P1 and the protease 3C of foot and mouth disease virus (FMDV). The immunogenicity of the expressed products was tested using a mouse experimental model. Parenterally immunized mice developed a strong antibody response and were completely protected when challenged with the virulent virus. This report demonstrates the possibility of using transgenic plants to express polyprotein P1 and the protease 3C of FMDV and their utilization as effective experimental immunogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734052     DOI: 10.1016/j.vaccine.2004.11.014

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Plant derived veterinary vaccines.

Authors:  L Santi
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

2.  Cross-reactivity of anti-Eimeria tenella antibody fragments on merozoites and sporozoites of different chicken Eimeria species.

Authors:  Reda E Khalafalla; Arwid Daugschies; Viktor Dyachenko
Journal:  Parasitol Res       Date:  2010-11-24       Impact factor: 2.289

Review 3.  Plant-based vaccines for animals and humans: recent advances in technology and clinical trials.

Authors:  Natsumi Takeyama; Hiroshi Kiyono; Yoshikazu Yuki
Journal:  Ther Adv Vaccines       Date:  2015-09

4.  Tissue culture independent transformation of the forage crop sunnhemp (Crotalaria juncea L.): an easy method towards generation of transgenics.

Authors:  Jyothsna P Rao; Pushpa Agrawal; Riaz Mahmood; Rohini Sreevathsa; K Sankara Rao; G R Reddy; V V S Suryanarayana
Journal:  Physiol Mol Biol Plants       Date:  2011-12-10

5.  The High Immunity Induced by the Virus-Like Particles of Foot-and-Mouth Disease Virus Serotype O.

Authors:  Yan Xiao; Suling Zhang; He Yan; Xiaolin Geng; Yanwei Wang; Xin Xu; Mengyue Wang; Haohao Zhang; Baicheng Huang; Wenqiang Pang; Ming Yang; Kegong Tian
Journal:  Front Vet Sci       Date:  2021-02-25

6.  Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.

Authors:  Michael Puckette; Benjamin A Clark; Justin D Smith; Traci Turecek; Erica Martel; Lindsay Gabbert; Melia Pisano; William Hurtle; Juan M Pacheco; José Barrera; John G Neilan; Max Rasmussen
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

7.  Minimally processed crude leaf extracts of Nicotiana benthamiana containing recombinant foot and mouth disease virus-like particles are immunogenic in mice.

Authors:  Vanesa Ruiz; Josefina Baztarrica; Edward P Rybicki; Ann E Meyers; Andrés Wigdorovitz
Journal:  Biotechnol Rep (Amst)       Date:  2018-09-28

8.  Development of a foot-and-mouth disease virus serotype A empty capsid subunit vaccine using silkworm (Bombyx mori) pupae.

Authors:  Zhiyong Li; Yongzhu Yi; Xiangping Yin; Yun Zhang; Ming Liu; Hang Liu; Xuerui Li; Yinü Li; Zhifang Zhang; Jixing Liu
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

9.  Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine.

Authors:  Zhiyong Li; Yongzhu Yi; Xiangping Yin; Zhifang Zhang; Jixing Liu
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

10.  Oral immunization with recombinant protein antigen expressed in tobacco against fish nervous necrosis virus.

Authors:  Ho Seong Cho; Ja Young Seo; Sang Ik Park; Tae Geum Kim; Tae Jung Kim
Journal:  J Vet Med Sci       Date:  2017-12-18       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.